Hypermarcas (OTCMKTS:HYPMY) Share Price Passes Below 50-Day Moving Average – Here’s What Happened

Shares of Hypermarcas (OTCMKTS:HYPMYGet Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $4.37 and traded as low as $4.00. Hypermarcas shares last traded at $4.1125, with a volume of 736 shares traded.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Check Out Our Latest Research Report on HYPMY

Hypermarcas Stock Down 2.3%

The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 8.57 and a beta of 0.70. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The firm has a 50 day moving average price of $4.37 and a two-hundred day moving average price of $4.40.

Hypermarcas (OTCMKTS:HYPMYGet Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The business had revenue of $383.13 million during the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. On average, equities analysts expect that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

Featured Stories

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.